Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.

Publisher Website
Google Scholar
Abstract
The increasing recognition that women who are unable or unwilling to discuss or use condoms with their sexual partners need female-controlled methods for preventing sexually transmitted diseases (STDs), including HIV, has led to considerable focus on the development of vaginal microbicides. While many such products are being tested for safety and effectiveness, clinical trials generally overlook another key factor in a product's impact on infection rates-its acceptability to users.

This publication has 0 references indexed in Scilit: